NCT07898215 Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
| NCT ID | NCT07898215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adiyaman University |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-11-04 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-11-04 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate whether reduced heart function is associated with differences in stomach contents before elective coronary artery bypass graft (CABG) surgery. Patients undergoing elective cardiac surgery will be divided into two groups based on their left ventricular ejection fraction (LVEF), a measure of how well the heart pumps blood: patients with an LVEF below 40% and patients with an LVEF of 40% or higher. Before surgery, the researchers will use ultrasound to examine the stomach. They will assess the presence and amount of stomach contents using the Perlas grading system and ultrasound measurements of the gastric antrum. The main objective is to compare gastric ultrasound findings between the two groups. The researchers will also evaluate estimated gastric volume and the frequency of stomach findings associated with a higher risk of aspiration during anesthesia.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years. * Scheduled for elective coronary artery bypass grafting (CABG) surgery with cardiopulmonary bypass. * Willingness to participate in the study and provision of written informed consent. Exclusion Criteria: * Emergency surgery. * History of upper gastrointestinal surgery. * Known gastroparesis or severe gastrointestinal motility disorders. * Active nausea or vomiting. * Body mass index (BMI) \>40 kg/m². * History of gastroesophageal reflux disease (GERD). * Inability to cooperate with gastric ultrasonography assessment. * Refusal to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07898215 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07898215 currently recruiting?
Yes, NCT07898215 is actively recruiting participants. Contact the research team at fadimetosun@gmail.com for enrollment information.
Where is the NCT07898215 trial being conducted?
This trial is being conducted at Adıyaman, Turkey (Türkiye).
Who is sponsoring the NCT07898215 clinical trial?
NCT07898215 is sponsored by Adiyaman University. The trial plans to enroll 50 participants.